News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel Backs Human Genome Sciences, Inc. (HGSI)'s Drug, Benlysta for Lupus


11/17/2010 7:53:51 AM

Wall Street Journal -- Experimental lupus drug Benlysta — co-developed by Human Genome Sciences and GlaxoSmithKline — moved one step closer to approval yesterday. An FDA advisory panel voted to recommend approval by a sizeable margin: 13-2, as the WSJ reports.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES